KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Exchange Rate Effect (2016 - 2025)

Arbutus Biopharma (ABUS) has disclosed Exchange Rate Effect for 13 consecutive years, with $1000.0 as the latest value for Q4 2025.

  • Quarterly Exchange Rate Effect rose 103.03% to $1000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14000.0 through Dec 2025, up 128.57% year-over-year, with the annual reading at $14000.0 for FY2025, 128.57% up from the prior year.
  • Exchange Rate Effect hit $1000.0 in Q4 2025 for Arbutus Biopharma, up from -$12000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $44000.0 in Q3 2021 to a low of -$44000.0 in Q1 2021.
  • Historically, Exchange Rate Effect has averaged -$1588.2 across 5 years, with a median of $1000.0 in 2025.
  • Biggest five-year swings in Exchange Rate Effect: surged 450.0% in 2023 and later plummeted 700.0% in 2024.
  • Year by year, Exchange Rate Effect stood at $5000.0 in 2021, then crashed by 180.0% to -$4000.0 in 2022, then soared by 450.0% to $14000.0 in 2023, then plummeted by 335.71% to -$33000.0 in 2024, then skyrocketed by 103.03% to $1000.0 in 2025.
  • Business Quant data shows Exchange Rate Effect for ABUS at $1000.0 in Q4 2025, -$12000.0 in Q3 2025, and $21000.0 in Q2 2025.